I agree that this site is using cookies. You can find further informations here.
X
Palmieri, Raffaele
177  results:
OpenAccess-fulltext X
english X
?
1

P505: GIMEMA AML1819 TRIAL: GEMTUZUMAB OZOGAMICIN PLUS INTE..:

Venditti, Adriano ; Piciocchi, Alfonso ; Maurillo, Luca...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429782/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Time for Dynamic Assessment of Fitness in Acute Myeloid Leu..:

Palmieri, Raffaele ; Maurillo, Luca ; Del Principe, Maria Ilaria...
info:eu-repo/semantics/altIdentifier/wos/WOS:000911127100001.  , 2023
Link: https://hdl.handle.net/2..
 
?
3

Editorial: Measurable residual disease in hematologic malig..:

Buccisano, Francesco ; Palmieri, Raffaele ; Guzman, Monica L.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206393/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Measurable Residual Disease (MRD) as a Surrogate Efficacy-R..:

Meddi, Elisa ; Savi, Arianna ; Moretti, Federico...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967250/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

FEVER OF UNKNOWN ORIGIN AND MULTIDRUG-RESISTANT ORGANISMS C..:

Guarnera, Luca ; Trotta, Gentiana Elena ; Boldrini, Valentina...
info:eu-repo/semantics/altIdentifier/pmid/36660358.  , 2023
Link: https://hdl.handle.net/2..
 
?
6

THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIE..:

Palmieri, Raffaele ; Del Principe, Ilaria ; Maurillo, Luca..
info:eu-repo/semantics/altIdentifier/pmid/37705524.  , 2023
Link: https://hdl.handle.net/2..
 
?
7

P523: The comparison of VFLAI, FLAI and 3 + 7 regimens by m..:

Piciocchi, Alfonso ; Marconi, Giovanni ; Cipriani, Marta...
European Hematology Association (EHA) 2023 Congress.  , 2023
Link: https://hdl.handle.net/1..
 
?
8

P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED ..:

Tettero, Jesse ; Palmieri, Raffaele ; Lam Ngai, Lok...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429573/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY M..:

Piciocchi, Alfonso ; Marconi, Giovanni ; Cipriani, Marta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429401/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Efficacy and safety of nilotinib as frontline treatment in ..:

Luciano, Luigia ; Latagliata, Roberto ; Gugliotta, Gabriele...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182159/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
11

Measurable Residual Disease (MRD) as a Surrogate Efficacy-R..:

Meddi, Elisa ; Savi, Arianna ; Moretti, Federico...
info:eu-repo/semantics/altIdentifier/pmid/36834477.  , 2023
Link: https://hdl.handle.net/2..
 
?
12

Case report: A Saprochaete clavata (Magnusiomyces clavatus)..:

Pasqualone, Gianmario ; Buzzatti, Elisa ; Palmieri, Raffaele...
info:eu-repo/semantics/altIdentifier/wos/WOS:000862193800001.  , 2022
Link: http://hdl.handle.net/21..
 
?
13

Vitamin C Deficiency in Patients With Acute Myeloid Leukemi:

Ottone, Tiziana ; Faraoni, Isabella ; Fucci, Giorgio...
info:eu-repo/semantics/altIdentifier/pmid/35832559.  , 2022
Link: https://hdl.handle.net/2..
 
?
14

Pulmonary function testing for fitness assessment in asympt..:

Palmieri, Raffaele ; Othus, Megan ; Cheng, Guang-Shing...
info:eu-repo/semantics/altIdentifier/pmid/35924584.  , 2022
Link: https://hdl.handle.net/2..
 
?
15

Predictors of Early Thrombotic Events in Adult Patients wit..:

Paterno, Giovangiacinto ; Palmieri, Raffaele ; Forte, Vittorio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688263/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15